Shandong Boan Biotechnology Transfers 38.5 Million H Shares to New Investor
I'm PortAI, I can summarize articles.
Shandong Boan Biotechnology Co. Ltd. announced that its controlling shareholder, Luye Pharma Group Ltd., will transfer 38.5 million H Shares to the Issuer on January 22, 2026. This transfer is part of a subscription agreement related to Exchangeable Preference Shares. The board expects no material adverse effect on the company's operations from this transaction.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments